Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$12.80 -0.32 (-2.44%)
At close: Oct 23, 2026 · 4:00 PM EDT

Eloxx Pharmaceuticals (ELOX) Non Operating Investment Income (2016)

Updated

Eloxx Pharmaceuticals (ELOX) recorded Non Operating Investment Income of $149,728 in FY2017.

Analysis

Eloxx Pharmaceuticals (ELOX) Non Operating Investment Income (2016) Analysis & Trends

  • Per Business Quant data, ELOX's Non Operating Investment Income was $149,728 in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Eloxx Pharmaceuticals 86.90 Mn 13.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 149,728.00
API Access

Eloxx Pharmaceuticals Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ELOX&period=max&api_key=YOUR_API_KEY